Related Experiment Video
Updated: Apr 13, 2026

14:36
Combining QD-FRET and Microfluidics to Monitor DNA Nanocomplex Self-Assembly in Real-Time
Published on: August 26, 2009
11.1K
Fluorescent Self-Assembled Complexes Based on Glyco-Functionalized G-Quadruplexes as a Targeted Delivery Platform.
Xian Wang1, Hui Ling Seah2, Xiao-Lin Zhang1
1School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 21 Nanyang Link, Singapore 637371, Singapore.
ACS Applied Materials & Interfaces
|September 12, 2024
Summary
We developed pH-sensitive self-assembled complexes (SACs) for targeted drug delivery. These complexes selectively target cancer cells, reducing side effects and enhancing anticancer efficacy for precision medicine.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Precision medicine requires advanced drug delivery systems for enhanced efficacy and reduced toxicity.
- Stimuli-responsive release and targeted delivery are key features for ideal therapeutic platforms.
- Developing versatile platforms with simple preparation and combinational payload capabilities is crucial.
Purpose of the Study:
- To develop pH-sensitive fluorescent self-assembled complexes (SACs) for targeted drug delivery.
- To create a versatile platform capable of co-delivering therapeutic agents.
- To evaluate the targeted delivery, safety, and efficacy of the developed SACs.
Main Methods:
- Nanoprecipitation method was used to synthesize galactose-functionalized G-quadruplex (G4) and coumarin carboxamidine derivative SACs.
- Fluorescence imaging was employed to assess the selective targeting of hepatocellular carcinoma (HepG2) cells.
- Co-delivery studies were performed with prodrug floxuridine oligomers and SACs to evaluate cytotoxicity on normal (NIH/3T3) and cancer cells.
Main Results:
- The developed SACs demonstrated selective targeting of HepG2 cells.
- Co-delivery of floxuridine oligomers with SACs significantly reduced cytotoxicity to normal cells while maintaining anticancer efficacy.
- The platform showed potential for targeted combinational therapy with minimal hemolytic effects.
Conclusions:
- pH-sensitive fluorescent SACs serve as an effective targeted delivery platform for precision medicine.
- The strategy enables selective cancer cell targeting and reduced systemic toxicity.
- This self-assembly approach is extendable to ratiometric multidrug delivery for enhanced combinational therapy.
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
141
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
141
Site-Targeted Drug Delivery Systems: Polymeric Carriers
127
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
127

